CVE-2025-7674: Roche Diagnostics navify Monitoring · Improper Input Validation
Affects Roche Diagnostics navify MonitoringSource CVE Database V5
Not known to be exploited · CVSS 7.1 High.
Data as of 26 Oct 2026, 06:26 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 19% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/S:N/AU:Y/R:U/V:D/RE:M/U:GreenExploitation evidence
Disclosed: evidence found.
CVE published 5 Aug 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-26.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Roche Diagnostics navify Monitoring | Affected
| Fixed in– |
AI-suggested
European healthcare organizations should prioritize upgrading navify Monitoring to version 1.08.00 or later once available, as this will likely contain the necessary fixes. Until a patch is released, organizations should implement network-level protections such as strict input validation proxies or web application firewalls (WAFs) configured to detect and block anomalous or malformed input patterns targeting navify Monitoring interfaces. Monitoring network traffic for unusual spikes or malformed requests can help detect early exploitation attempts. Segmentation of the network to isolate navify Monitoring servers from less trusted networks can reduce exposure. Additionally, applying rate limiting on incoming requests to the affected service can mitigate the risk of resource exhaustion. Regular backups and incident response plans should be updated to handle potential DoS scenarios. Collaboration with Roche Diagnostics support for guidance and timely updates is recommended.
Description
Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.